Table 2.
Overview of the nonadoption, abandonment, scale-up, spread, and sustainability (NASSS) framework used to evaluate the success of the IBD-live telemonitoring strategy. The left column shows the original NASSS questions, the right column shows how we adapted some to assess local applicability.
| Domain and questions | Adapted questions | |
| Domain 1: The illness | ||
| 1A. What is the nature of the condition or illness? | How well does the Flarometer strategy predict out-of-range or all-is-well events? | |
| 1B. What are the relevant sociocultural factors and comorbidities? | What are the sociocultural factors associated with good adherence to the technology? (Original RCTa)b | |
| Domain 2: The technology | ||
| 2A. What are the key features of the technology? | No changes | |
| 2B. What kind of knowledge does the technology bring into play? | No changes | |
| 2C. What knowledge and/or support is required to use the technology? | No changes | |
| 2D. What is the technology supply model? | No changes | |
| Domain 3: The value proposition | ||
| 3A. What is the developer’s business case for the technology (supply-side value)? | No changes | |
| 3B. What is the desirability, efficacy, safety, and cost effectiveness of the technology (demand-side value)? | What is the change from baseline in quality-of-life and cost-effectiveness? (Original RCT)b | |
| Domain 4: The adopter system | ||
| 4A. What changes in staff roles, practices, and identities are implied? | No changes | |
| 4B. What is expected of the patient (and/or immediate caregiver)—is this achievable by, and acceptable to, them? | No changes | |
| 4C. What is assumed about the extended network of lay caregivers? | Not applicable | |
| Domain 5: The organization | ||
| 5A. What is the organization’s capacity to innovate? | No changes | |
| 5B. How ready is the organization for this technology-supported change? | No changes | |
| 5C. How easy will the adoption and funding decision be? | No changes | |
| 5D. What changes will be needed in team interactions and routines? | No changes | |
| 5E. What work is involved in implementation and who will do it? | No changes | |
| Domain 6: The wider context | ||
| 6A. What is the political, economic, regulatory, professional (eg, medicolegal), and sociocultural context for program rollout? | No changes | |
| Domain 7: The time dimension | ||
| 7A. How much scope is there for adapting and coevolving the technology and the service over time? | No changes | |
| 7B. How resilient is the organization to handling critical events and adapting to unforeseen eventualities? | No changes | |
aRCT: randomized controlled trial.
bWe already published the results of this measure in the original RCT [5].